Study guide

8.2 Caregiver Planning, Financial & Cultural Navigation, and Sexual Health

Transplantation and Cellular Therapy Certified Nurse TCTCN

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 The TCTCN Credential: Rename, Scope & Official Test Blueprint 1.2 TCTCN Eligibility, Test-Day Logistics, Scoring & Renewal 1.3 Building the Study Plan & Clinical Prioritization Framework 1.4 Clinical Triage Rehearsal & Exam-Day Question Strategy

2 Chapter 2: Foundations of Transplantation & Cellular Biology

2.1 Hematopoietic Lineage, the MHC & HLA Class I vs Class II Biology 2.2 HLA Typing Resolution, Donor Matching, DSA & ABO Compatibility 2.3 Disease Indications & the Cellular Therapy Modality Map 2.4 Pre-Transplant Risk Stratification & Organ Suitability Assessment 2.5 Stem Cell & Cellular Product Sources: Donor Selection Hierarchy 2.6 Conditioning Regimens & Lymphodepletion Principles 2.7 Recipient and Caregiver Education Across the Continuum

3 Chapter 3: Product Collection, Processing & Infusion Procedures

3.1 Stem Cell Mobilization: Niche Biology, Agents & CD34+ Collection Targets 3.2 Apheresis Nursing Care: Vascular Access, Citrate Toxicity & Donor Safety 3.3 Graft Engineering, ABO-Directed Processing & Cryopreservation Science 3.4 DMSO Toxicity, Premedication & Time-Critical Thawed Product Administration 3.5 Pre-Administration Verification, Equipment & CAR T Infusion Readiness 3.6 Infusion Monitoring & Acute Reaction Differential Management 3.7 Engraftment Definitions, Kinetics & Factors Impairing Recovery 3.8 Graft Failure Classification & Donor Chimerism Tracking

4 Chapter 4: Acute Post-HSCT Complications & Graft-versus-Host Disease

4.1 Acute GVHD: Billingham's Postulates, Classification & the Ferrara 3-Phase Model 4.2 Acute GVHD Organ Manifestations, Histopathology & MAGIC Staging 4.3 MAGIC Overall Grading & Acute GVHD Plasma Biomarkers 4.4 Acute GVHD Prophylaxis, First-Line Steroids & Steroid-Refractory Therapy 4.5 SOS/VOD: Microvascular Pathophysiology & Risk Stratification 4.6 SOS/VOD Diagnostic Criteria, Surveillance & Defibrotide Therapy 4.7 TA-TMA: Complement Pathophysiology, Harmonized Criteria & Differential 4.8 TA-TMA Management, Complement-Directed Therapy & Other Endothelial Syndromes

5 Chapter 5: Post-Transplant Infections & Supportive Care

5.1 Neutropenic Fever, Pre-Engraftment Phase & Empiric Antimicrobial Therapy 5.2 CMV: Risk Stratification, Letermovir Prophylaxis & DNAemia Treatment 5.3 EBV/PTLD, HHV-6 Encephalitis, BK Cystitis, Adenovirus, HSV & VZV 5.4 Invasive Fungal Infections (Aspergillus, Candida, Mucor) & PJP Prophylaxis 5.5 Supportive Care in Aplasia: Transfusion Guidelines, Oral Mucositis & Nutrition

6 Chapter 6: Post-Cellular Therapy Management, CRS & ICANS

6.1 CAR Structural Architecture, Generations & Costimulatory Domain Biology 6.2 The Vein-to-Vein Lifecycle, In Vivo Kinetics & On-Target B-Cell Aplasia 6.3 CRS Pathophysiology, Clinical Kinetics & Inflammatory Biomarkers 6.4 ASTCT CRS Grading, Tocilizumab & Escalation Management 6.5 ICANS: Assessment, ICE Scoring & Clinical Management 6.6 Delayed Cellular Toxicities: Prolonged Cytopenias, B-Cell Aplasia & IEC-HS 6.7 Symptom Management and Functional Recovery After Cellular Therapy

7 Chapter 7: Chronic GVHD & Long-Term Survivorship

7.1 Chronic GVHD: Three-Phase Immunobiology & NIH Classification 7.2 Chronic GVHD Diagnostic Manifestations, BOS & NIH Global Severity Scoring 7.3 Chronic GVHD: Systemic, Steroid-Sparing & Multidisciplinary Therapy 7.4 Late Effects: Endocrine, Cardiovascular, Bone Health & Secondary Malignancies 7.5 Immune Reconstitution & the Inactivated Re-Vaccination Schedule 7.6 Live Vaccines, Household Contact Precautions & Survivorship Care Plans 7.7 Post-HSCT Relapse: Surveillance, Immunologic Manipulation & Treatment

8 Chapter 8: Quality of Life, Ethics & Professional Practice Standards

8.1 Psychosocial Trajectories, Distress Screening & Delirium Assessment 8.2 Caregiver Planning, Financial & Cultural Navigation, and Sexual Health 8.3 Palliative Care Integration, Advance Directives & Ethical Considerations 8.4 FACT-JACIE Quality Standards, CIBMTR / NMDP Reporting & Compliance 8.5 Evidence-Based Practice, Discharge Education & Quality Improvement

8.2 Caregiver Planning, Financial & Cultural Navigation, and Sexual Health

Key Takeaways Explain This Topic AI

Caregiver capacity, housing and proximity requirements are product-, program-, setting- and patient-specific; assess burden and build safe backup plans instead of treating one person as an unlimited resource.

Current autologous CD19/BCMA CAR T labels generally instruct proximity to a healthcare facility and no driving for at least two weeks with daily early monitoring, but they do not establish one universal 24/7 caregiver duration - so teach the actual product and program plan rather than a memorized rule.

Use qualified interpreters, ask rather than assume beliefs and family roles, preserve patient autonomy/privacy, and coordinate safe accommodations with the patient's permission.

Normalize sexual-health assessment and refer persistent pain, genital GVHD, endocrine dysfunction, fertility concerns or relationship distress for individualized multidisciplinary care.

Last updated: September 2026

1. Caregiver and Support Planning

Caregivers may face anxiety, depression, sleep loss, financial strain, physical fatigue and medication responsibility. Ask about the caregiver's own health, understanding, willingness, rest, work/childcare, crisis risk and backup help. Use teach-back only for tasks actually assigned; do not assume every caregiver will flush a line or provide continuous observation.

HCT support and lodging rules follow transplant type, inpatient/outpatient model, distance, patient function and center policy. Current autologous CD19/BCMA CAR T labels generally instruct proximity to a healthcare facility and no driving for at least two weeks, with daily early monitoring, but they do not establish one universal 24/7 caregiver duration. Explain the actual product/program plan, urgent symptoms, contacts and transportation. When sleep deprivation or burden threatens safety, assess immediately and coordinate respite, alternate support, home services, lodging or a different care setting.

Support domain What to assess directly Findings that require immediate action

Caregiver health & capacity The caregiver's own medical conditions, sleep, fatigue, mood, and willingness to take on assigned tasks Sleep deprivation or burden that threatens patient safety; caregiver crisis risk

Task competence Teach-back on the tasks actually assigned (not every possible task) Inability to perform an assigned line, medication, or monitoring task

Proximity & transportation Distance to the treating facility, driving restrictions, and reliable transport for daily early monitoring No transport plan during the product-defined monitoring window

Backup support Named alternate caregivers, respite options, home services, and lodging A single caregiver with no backup for a high-risk outpatient plan

Work, childcare & finances Employment, leave eligibility, dependent care, and out-of-pocket burden Financial toxicity driving nonadherence or missed appointments

2. Psychological and Financial Navigation

CBT/CBT-I, acceptance-based approaches, mindfulness, medication and peer support may help selected patients; match intervention to diagnosis, access, culture and preference. Financial toxicity includes medication cost, lodging, travel, insurance, fertility, lost income and caregiver work disruption and can contribute to nonadherence and worse outcomes. Ask directly and early. Social workers and financial navigators can review insurance/leave/disability eligibility, manufacturer or nonprofit assistance, transportation/lodging and medication alternatives. Program availability changes, so verify current eligibility rather than promising a named grant.

3. Culturally and Spiritually Responsive Navigation

Ask each person—do not infer—about preferred language, health literacy, decision-makers, family roles, food practices, modesty, touch, blood-product concerns, religious observances, rituals, and sources of meaning or distress. Use a qualified medical interpreter for clinical communication and direct questions to the patient, not the interpreter. Document the patient's own goals and chosen support people while preserving privacy and autonomy.

Translate beliefs into a safe plan: coordinate fasting or traditional practices with medication/conditioning needs; involve pharmacy, nutrition, ethics, social work, cultural liaisons, or chaplain/spiritual care with permission; and offer equivalent options rather than labeling a person “nonadherent.” Navigation also addresses transportation, housing, digital access, insurance, disability, food security, fertility, sexual health, and return-to-work barriers across the continuum. Spiritual care may include meaning, hope, grief, guilt, prayer/ritual, or no religious framework at all. Reassess preferences as illness and goals change.

4. Sexual Health and Intimacy

Use permission-based language such as PLISSIT to normalize sexual-health concerns. Assess desire, arousal/erection, orgasm, pain, dryness, body image, fertility, relationship safety, medicines, endocrine symptoms and genital GVHD without assumptions about anatomy, partners or goals.

For vaginal dryness or pain, nonhormonal moisturizers and compatible lubricants may help. Suspected genital GVHD, erosions or stenosis requires gynecology and transplant evaluation; site-appropriate topical anti-inflammatory therapy, local hormone therapy, pelvic-floor therapy or dilators may be prescribed after infection, malignancy and contraindication review. Erectile dysfunction or hypogonadal symptoms require medication, vascular/endocrine and relationship assessment; PDE5 inhibitors or testosterone are used only when clinically appropriate. Teach infection/bleeding precautions and contraception/fertility guidance for the individual rather than fixed product frequencies.

5. Fertility, Contraception and Family Building as Navigation Work

Fertility is the topic patients most often report was mentioned once, quickly, at a moment when they could not absorb it. Treating it as navigation rather than as a single consent conversation changes the outcome.

Timing governs the options. Preservation must occur before gonadotoxic conditioning or lymphodepletion, and the methods differ substantially in how long they take. Sperm cryopreservation can often be completed within days; oocyte or embryo cryopreservation requires an ovarian stimulation cycle measured in weeks; ovarian or testicular tissue approaches are offered in specialized programs and may be the only option for prepubertal patients. Raise the referral at the first evaluation for every patient of reproductive potential, regardless of relationship status, sex, gender identity, or previously stated intentions, and document the discussion and the decision.

Cost is frequently the real barrier. Preservation and storage are often poorly covered, storage fees recur annually, and patients quietly decline for financial reasons they do not state. Ask directly, involve the financial navigator immediately rather than after the decision, and check current manufacturer, nonprofit, and program assistance rather than assuming none exists.

Contraception is a separate conversation from fertility. Reduced fertility is not the same as infertility, and pregnancy during or shortly after conditioning, immunosuppression, or gene-modified cellular therapy carries teratogenic and clinical risk. Counsel on effective contraception for the duration the treating team specifies for the individual regimen and product, and address both partners rather than assuming who carries the risk.

Family building continues after treatment. Survivors ask about pregnancy safety, gestational carriers, adoption, and donor gametes years later, often of a primary care clinician who does not know the transplant history. Record fertility status, preservation performed and where material is stored, contraception guidance, and the referral pathway in the survivorship plan so that the conversation can be picked up rather than restarted.